Speaker: Federico Mingozzi, PhD, MBA
Chief Executive Officer, Nava Therapeutics
About the Seminar
“Overcoming delivery barriers in genetic medicine”
Federico Mingozzi, Ph.D., is the Chief Executive Officer of Nava Therapeutics. His career has been dedicated to developing safe and effective gene-based treatments for both genetic and acquired diseases. His academic research focused on understanding the interactions between gene therapy vectors and the host immune system, as well as the development and clinical translation of adeno-associated virus (AAV)-based gene therapies.
At Nava Therapeutics, Dr. Mingozzi leads an organization focused on overcoming the limitations of non-viral delivery and advancing mRNA-based therapeutics. He is deeply committed to science, the development of transformative therapies for patients, and mentoring the next generation of gene therapy researchers.
Event Details
- Date: April 27, 2026
- Time: 11:30 a.m. – 12:30 p.m.
- Location: BST3 6014